Ex Vivo Major Histocompatibility Complex I Knockdown Prolongs Rejection-free Allograft Survival

BACKGROUND: Widespread application of vascularized composite allotransplantation (VCA) is currently limited by the required lifelong systemic immunosuppression and its associated morbidity and mortality. This study evaluated the efficacy of ex vivo (after procurement but before transplantation) engi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Plast Reconstr Surg Glob Open
Main Authors: Chang, Jessica B., Rifkin, William J., Soares, Marc A., Duckworth, April, Rao, Nakul, Low, Yee Cheng, Massie, Jonathan P., Rabbani, Piul S., Saadeh, Pierre B., Ceradini, Daniel J.
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2018
Assuntos:
Experimental
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6157929/
https://ncbi.nlm.nih.gov/pubmed/30276052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GOX.0000000000001825
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados